Eli Lilly's Mounjaro diabetes and weight-loss drug approved in India in KwikPen device, offering personalized treatment ...

Eli Lilly and Company (NYSE:LLY) is one of Best Dividend Stocks to Buy for Dependable Dividend Growth. According to Adam ...

A new injectable weight loss treatment from the maker of Ozempic and Wegovy delivered 23% weight loss in trials, according to findings published in the New England journal and medicine. Dr. Roshini ...

I'm in London, and I just paid for this damn fat drug I take. I said, it's not working. They said, he said, I just paid $88 ...

According to the National Family Health Survey-5 (2019–21), 24% of Indian women and 23% of Indian men are either overweight ...

Eli Lilly and Company (NYSE:LLY)’s diabetes drug is Mounjaro, while Zepbound is its treatment for obesity. Ricks made the following statement in an interview with ” Squawk Box ” on May 1: ...

Novo Nordisk has brought Wegovy, its once-a-week anti-obesity injection, to India starting at a price of ₹4,336.25— adding a ...

With CT scans picking up more cases of sclerosing mesenteritis, be prepared to diagnose this poorly understood autoimmune ...

Like everything else related to the Indiana Fever, corporate sponsorship for the WNBA team was one thing in the B.C.C. Era ...

Questions remain as to how FDA inspection differences between domestic and foreign drug facilities will play out.

US stock markets experienced a slight downturn on Tuesday, influenced by disappointing retail sales data and heightened geopolitical tensions involving Iran. Declining consumer spending raised ...